Literature DB >> 3312262

Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice.

M J Cannon1.   

Abstract

A rapid microplaque technique was developed for the detection of infectious respiratory syncytial virus (RSV) in the lungs of infected mice. Infected lung homogenates were titrated on microwell HEp-2 monolayers and incubated for 24 or 48 h. The microwells were then fixed with 4% formaldehyde in saline, or methanol containing 0.5% hydrogen peroxide. 24-h single cell infectious foci and 48-h microplaques were detected by an indirect immunoperoxidase (IIP) assay using monoclonal antibodies specific for RSV envelope glycoproteins as the first layer. This method can be used for the quantification of lung RSV in large numbers of samples much more rapidly and economically than conventional plaque assay techniques. In addition, the use of the IIP assay renders the system specific for RSV.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312262     DOI: 10.1016/0166-0934(87)90014-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.

Authors:  P J Openshaw; K Anderson; G W Wertz; B A Askonas
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus.

Authors:  P J Openshaw
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection.

Authors:  L H Thomas; M I Wickremasinghe; M Sharland; J S Friedland
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells.

Authors:  W H Alwan; F M Record; P J Openshaw
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

6.  Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells.

Authors:  Ralf Arnold; Manfred Neumann; Wolfgang König
Journal:  Immunology       Date:  2007-05       Impact factor: 7.397

7.  A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus.

Authors:  Laxmi Iyer Ravi; Liang Li; Richard Sutejo; Hui Chen; Pui San Wong; Boon Huan Tan; Richard J Sugrue
Journal:  BMC Genomics       Date:  2013-03-18       Impact factor: 3.969

8.  Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.

Authors:  M J Cannon; P J Openshaw; B A Askonas
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

9.  The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.

Authors:  Silke M Currie; Emily Gwyer Findlay; Brian J McHugh; Annie Mackellar; Tian Man; Derek Macmillan; Hongwei Wang; Paul M Fitch; Jürgen Schwarze; Donald J Davidson
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

Review 10.  Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.

Authors:  Gisela Canedo-Marroquín; Orlando Acevedo-Acevedo; Emma Rey-Jurado; Juan M Saavedra; Margarita K Lay; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2017-08-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.